Explaining Analytical Methods
- Report
Answers to Questions for the Record Following a Hearing on Health Care Spending
The Subcommittee on Health of the House Committee on Energy and Commerce convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
Answers to Questions for the Record Following a Hearing on Alternative Payment Models and the Slowdown in Federal Health Care Spending
The Senate Committee on the Budget convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
Federal Budgetary Effects of the Activities of the Center for Medicare & Medicaid Innovation
CBO estimates that the Center for Medicare & Medicaid Innovation’s (CMMI’s) activities increased federal spending between 2011 and 2020 and will also increase it from 2021 to 2030. In 2010, CBO projected that CMMI would produce savings.
- Report
The Medicare and Medicaid Improvement Funds: Budgetary History and Projections
CBO describes features of the Medicare and Medicaid improvement funds and how the funds are accounted for in CBO’s baseline and cost estimates.
- Report
Financial Commitments of Federal Credit and Insurance Programs, 2012 to 2021
CBO describes the commitments the federal government has made through its credit and insurance programs, including housing, real estate, and student loan programs, deposit insurance, insurance for private pensions, and flood and crop insurance.
- Working Paper
Defined Benefit and Defined Contribution Plans and the Distribution of Family Wealth: Working Paper 2023-02
Using data from 1989 through 2019, the paper examines how changes in retirement wealth, including those stemming from the shift from defined benefit to defined contribution plans, affect measures of wealth concentration.
- Presentation
Paying for Drugs in Medicare Part D Under Current Law and Under Proposals to Redesign the Program
In 2020, about three-fourths of Medicare beneficiaries were enrolled in Part D, the optional prescription drug benefit. They obtain coverage from private insurers, either through a stand-alone drug plan or through a Medicare Advantage plan.
- Report
A Comparison of Brand-Name Drug Prices Among Selected Federal Programs
CBO describes how the prices of brand-name prescription drugs are determined in different federal programs and compares drug prices among those programs in 2017.
- Working Paper
CBO’s Medicare Beneficiary Cost-Sharing Model: A Technical Description: Working Paper 2019-08
CBO uses a model to estimate the federal budgetary effects of proposed changes to the cost-sharing structure of the Medicare fee-for-service program. This paper describes that model, the analyses it can support, and an illustrative option for changing Medicare’s cost-sharing structure.
- Working Paper
The Effect of the Employer Match and Defaults on Federal Workers’ Savings Behavior in the Thrift Savings Plan: Working Paper 2019-06
This paper develops an empirical model to forecast the effects on employee contribution rates and on employer costs if the federal government changed the employer match or the default contribution rate for participants in the Thrift Savings Plan.